SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-064166
Filing Date
2019-11-14
Accepted
2019-11-14 16:06:17
Documents
49
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm1919620d1_10q.htm 10-Q 451688
2 EXHIBIT 31.1 tm1919620d1_ex31-1.htm EX-31.1 9472
3 EXHIBIT 32.1 tm1919620d1_ex32-1.htm EX-32.1 4320
  Complete submission text file 0001104659-19-064166.txt   4042916

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20190930.xml EX-101.INS 1019490
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20190930.xsd EX-101.SCH 31830
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20190930_cal.xml EX-101.CAL 35471
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20190930_def.xml EX-101.DEF 126070
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20190930_lab.xml EX-101.LAB 279673
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20190930_pre.xml EX-101.PRE 251427
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 191220052
SIC: 2836 Biological Products, (No Diagnostic Substances)